Researchers say statins may reduce lung cancer risk in men

05/7/2007 | Forbes

U.S. researchers say they found that patients taking statins for at least six months dropped their risk of lung cancer by 55%, with nearly all the patients being male. Researchers say protection by cholesterol-lowering statins appears to grow the longer they are taken, with those patients taking statins four years or more having a 77% reduction in lung cancer risk.

View Full Article in:

Forbes

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ
Chief Executive Officer
UCare Minnesota
Minneapolis, MN
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC